Cargando…

2471. The State of Cost-Utility Analyses in Vaccines: A Systematic Review

BACKGROUND: Economic evaluations are a major consideration of public health decisions on vaccine programs. Given the growth in the number of published cost-utility analyses of vaccines, we sought to better understand global trends in these studies by describing trends in growth, quality, and study f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jason, Lu, Patricia, Lam, Gary, Shin, Thomas, Chit, Ayman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255638/ http://dx.doi.org/10.1093/ofid/ofy210.2124

Ejemplares similares

Efficacy and Effectiveness of High-Dose Influenza Vaccine for Older Adults: A Systematic Review and Meta-Analysis
por: Lee, Jason, et al.
Publicado: (2017)

2745. Efficacy and Effectiveness of High-Dose Influenza Vaccine for Older Adults by Circulating Strain and Antigenic Match: A Systematic Review and Meta-Analysis
por: Lee, Jason K H, et al.
Publicado: (2019)

2471. Comparison of Dialysis Infection Events in Outpatient End Stage Renal Facilities Pre- and During the COVID-19 Pandemic: Louisiana, 2018-2021
por: Lee, Grace, et al.
Publicado: (2023)

2471. Review of Methicillin-Resistant Staphylococcus aureus, Clostridium difficile and Acquired Bloodstream Infections Across all United Kingdom Intensive Care Units following Implementation of a Statutory National Infection Control Campaign.
por: Batra, Rahul, et al.
Publicado: (2019)

Abstract No.: ABS2471: Comparison of landmark versus ECG-guided technique for correct insertion of central venous catheter in paediatric patients undergoing cardiothoracic surgery
por: Garg, Monika
Publicado: (2022)

2747. Relative Vaccine Efficacy of High-Dose vs. Standard Dose Influenza Vaccines in Preventing Probable Influenza in a US Medicare Fee-for-Service Population
por: Paudel, Misti, et al.
Publicado: (2019)

PB2471: EFFECT OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH MODIFIED FC PRETREATMENT REGIMEN ON SEX HORMONE LEVELS IN CHILDREN WITH SEVERE APLASTIC ANEMIA
por: MA, Liangming, et al.
Publicado: (2023)

An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model
por: Chit, Ayman, et al.
Publicado: (2015)

534. Healthcare Resource Utilization and Costs among Patients with COVID-19 in the United States
por: Liu, Gui, et al.
Publicado: (2023)

2457. Multivariate Analyses of Socio-Economic Inequities in Parental Awareness and Utilization of Meningococcal Serogroup B Vaccines
por: Huang, Liping, et al.
Publicado: (2018)

Water‐, pH‐ and temperature relations of germination for the extreme xerophiles Xeromyces bisporus (FRR 0025), Aspergillus penicillioides (JH06THJ) and Eurotium halophilicum (FRR 2471)
por: Stevenson, Andrew, et al.
Publicado: (2016)

2212 A systematic overview of cost-utility analyses in dermatology
por: Li, David G., et al.
Publicado: (2018)

102. Efficacy and Effectiveness of High-Dose Influenza Vaccine in Older Adults by Age and Seasonal Characteristics: An Updated Systematic Review and Meta-Analysis
por: Lee, Jason K, et al.
Publicado: (2022)

Global Patterns of QALY and DALY Use in Surgical Cost-Utility Analyses: A Systematic Review
por: Rios-Diaz, Arturo J., et al.
Publicado: (2016)

Acellular pertussis vaccines effectiveness over time: A systematic review, meta-analysis and modeling study
por: Chit, Ayman, et al.
Publicado: (2018)

Characteristics of health-state utilities used in cost-effectiveness analyses: a systematic review of published studies in Asia
por: Yang, Zhihao, et al.
Publicado: (2023)

Cost-utility of tDCS in depression treatment
por: Sauvaget, A.
Publicado: (2023)

The Opportunity Cost of Capital: Development of New Pharmaceuticals
por: Chit, Ayman, et al.
Publicado: (2015)

Economic evaluation of vaccines in Canada: A systematic review
por: Chit, Ayman, et al.
Publicado: (2016)

Frailty and Dementia: Differences in Health Care Utilization and Costs
por: Sison, Stephanie Denise, et al.
Publicado: (2021)

Determinants of Seasonal Influenza Vaccine Uptake Among the Elderly in the United States: A Systematic Review and Meta-Analysis
por: Okoli, George N., et al.
Publicado: (2019)

The Impact of Alzheimer’s Disease and Related Dementias on Dental Care Utilization and Costs in Older Adults
por: Li, Sam, et al.
Publicado: (2020)

2726. Meningococcal Vaccination Among Patients Newly Diagnosed at High-Risk for Meningococcal Disease in the United States
por: Bengtson, Lindsay, et al.
Publicado: (2019)

Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom
por: Thommes, Edward W., et al.
Publicado: (2015)

THE IMPACT OF THE R3 PROGRAM ON HEALTH SERVICES UTILIZATION AND COSTS
por: Tavares, Jane, et al.
Publicado: (2022)

1097 Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States
por: Yang, H. Keri, et al.
Publicado: (2014)

2170. The National Burden of Pneumonia and Influenza in U.S. Nursing Homes, 2013–2015
por: Mcconeghy, Kevin, et al.
Publicado: (2018)

1146. Cost-effectiveness of the Pentavalent Meningococcal Vaccine (MenABCWY): A steady-state cohort modelling approach
por: Schley, Katharina, et al.
Publicado: (2023)

High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors
por: Becker, Debbie L., et al.
Publicado: (2016)

The state of cost-utility analysis in India: A systematic review
por: Khurana, Tanu, et al.
Publicado: (2021)

Cost of hospital management of Clostridium difficile infection in United States—a meta-analysis and modelling study
por: Zhang, Shanshan, et al.
Publicado: (2016)

20. Cost-Effectiveness of Recombinant Zoster Vaccine for Vaccinating Immunocompromised Adults Against Herpes Zoster in the United States
por: Curran, Desmond, et al.
Publicado: (2021)

Utilization and Expenditures of High-Need, High-Cost Older Adults With Disabilities
por: Karon, Sarita, et al.
Publicado: (2021)

Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada
por: Delea, Thomas E., et al.
Publicado: (2017)

Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review
por: Grochtdreis, Thomas, et al.
Publicado: (2018)

Evaluation of health utility in trial-based cost–utility analyses for major cardiovascular disease: protocol for a systematic review
por: Nakao, Yasuhisa, et al.
Publicado: (2023)

Cost–utility and cost–benefit analyses of school-based obesity prevention program
por: Xu, Haiquan, et al.
Publicado: (2020)

A CITATION REVIEW OF DISSEMINATION AND IMPLEMENTATION MODELS UTILIZED IN AGING RESEARCH WITHIN THE UNITED STATES
por: Sullivan, Jennifer, et al.
Publicado: (2022)

Economic Assessment of High-Dose Versus Adjuvanted Influenza Vaccine: An Evaluation of Hospitalization Costs Based on a Cohort Study
por: van Aalst, Robertus, et al.
Publicado: (2021)

Healthcare Resource Utilization and Costs Following Diagnosis of Nontuberculous Mycobacterial Lung Disease in the USA
por: Marras, Theodore, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2onpbrbdcu52d2es47i1el4ng1